Updated November 30, 2025
Procter & Gamble (NYSE: PG) heads into the final month of 2025 looking oddly unloved for a classic “safety stock.” Shares last traded around $148 (as of the November 28 close), down roughly 17% over the past year and hovering not far above a 52‑week low near $144, despite rock‑solid earnings, a rising dividend and a massive cash‑return program. [1]
Yet beneath the sleepy share price, there’s a lot going on: an earnings beat, a multi‑billion‑dollar tariff bill, a restructuring that includes 7,000 job cuts, an exit from Pakistan, fresh product launches in beauty and home care, and new legal scrutiny of its Crest brands. Here’s how all the moving parts look today, November 30, 2025.
Where Procter & Gamble (PG) Stock Stands Now
- Latest price: about $148 per share, with a 52‑week range of roughly $144 to $180. [2]
- Valuation: around 21–22x trailing earnings, with a trailing EPS near $6.85. [3]
- Dividend yield: about 2.8–2.9% on an annual dividend of $4.23 per share. [4]
- Analyst targets: the average 12‑month target price is roughly $174–175, implying high‑teens upside from current levels. [5]
Analyst coverage is broadly constructive. Across multiple platforms, Procter & Gamble carries a “Moderate Buy” to “Buy” consensus, with a mix of Strong Buys and Holds. [6]
In other words: the market is pricing PG like a slightly bruised defensive name, while Wall Street models still treat it as a slow‑growing compounder with room to run.
Q1 FY26: Modest Growth, Big Cash and Steady Guidance
P&G’s latest numbers come from its fiscal Q1 2026 (quarter ended September 30, 2025), released on October 24. [7]
Key highlights:
- Net sales: $22.4 billion, up 3% year‑over‑year.
- Organic sales: up 2%, powered by a 1% price increase and a 1% favorable mix; volumes were flat. [8]
- Diluted EPS:$1.95, up 21%, boosted by lower restructuring charges versus last year.
- Core EPS:$1.99, up 3%, and above many Street estimates. [9]
- Operating cash flow:$5.4 billion in the quarter, with adjusted free cash flow productivity at 102%.
- Capital return: $3.8 billion returned to shareholders—about $2.55 billion in dividends and $1.25 billion in buybacks in just one quarter. [10]
By segment, organic sales were:
- Beauty: +6%
- Grooming: +3%
- Health Care: +1%
- Fabric & Home Care: flat
- Baby, Feminine & Family Care: flat [11]
So the growth engine is squarely in premium beauty, hair care and grooming, while laundry and paper categories are more sluggish.
Management kept full‑year guidance intact:
- All‑in sales growth: +1% to +5%
- Organic sales growth: 0% to +4%
- Core EPS: $6.83 to $7.09, implying flat to +4% growth vs. last year’s core EPS of $6.83. [12]
For a company this mature, low‑single‑digit growth with double‑digit margins and huge cash flow is basically the business model. The question investors are asking now is whether that stability is enough to justify the multiple given the new macro and regulatory headaches.
Tariffs: From $1 Billion Hit to a Smaller, Still‑Painful Bill
P&G is caught directly in the cross‑fire of the Trump administration’s expanding tariff regime.
Earlier this year, the company warned investors that new U.S. tariffs could add around $1 billion in extra costs, including roughly $200 million tied to materials and products imported from China, $600 million from imports to the U.S. from the rest of the world, and another $200 million from retaliatory tariffs on exports to Canada. [13]
Since then, there has been one small mercy: Canada lifted some retaliatory duties, allowing P&G to cut its tariff cost estimate in half to about $400 million after tax for this fiscal year. [14]
On the Q1 call and in subsequent commentary:
- Management noted that tariffs and related pricing moves shaved about 70 basis points off gross margin, contributing to a 50‑basis‑point decline in operating margin versus last year, even though price hikes and productivity savings helped offset some of the pressure. [15]
- CFO Andre Schulten described the consumer backdrop as “not great, but stable,” and said P&G is using a mix of smaller pack sizes and larger value packs to help different income tiers cope with higher prices. [16]
So: tariffs haven’t derailed the story, but they are a recurring drag. P&G’s strategy is essentially:
- Use innovation to justify higher prices.
- Use scale and productivity to absorb part of the cost.
- Accept somewhat lower margins to protect share if needed.
That trade‑off between stability and growth is exactly what several recent analyst pieces and Zacks’ commentary have been chewing on. [17]
Restructuring: Pakistan Exit, 7,000 Job Cuts and Portfolio Pruning
P&G is simultaneously tightening its footprint and revamping operations.
Exiting Pakistan, shifting to distributors
On October 2, the company announced it will wind down direct manufacturing and commercial operations in Pakistan, including Gillette Pakistan Ltd, and move to a third‑party distributor model. [18]
- P&G framed the move as part of a global push to “accelerate growth and value creation.”
- Impacted employees may be offered opportunities in other markets or separation packages, and the transition is expected to take several months. [19]
Coupled with its exit from laundry bar businesses in India and the Philippines, the Pakistan move fits a broader pattern: retreat from low‑margin or volatile markets/products while focusing capital on higher‑value branded categories. [20]
7,000 white‑collar jobs and a multi‑year restructuring
Reuters reports that P&G plans to cut about 7,000 non‑manufacturing roles over the next two years, as part of a restructuring aimed at making the organization leaner and more agile. The company expects $1.5–$2.0 billion in before‑tax restructuring charges spread across fiscal 2026 and 2027. [21]
From an equity perspective, this is classic “pay now, save later”:
- In the near term, restructuring charges inflate GAAP expenses and add noise.
- Over time, lower overhead should support margins and free up resources for innovation and marketing—if execution is solid.
Dividend Power and Shareholder Returns
At its October 14, 2025 annual meeting, P&G’s board declared a quarterly dividend of $1.0568 per share, payable November 17. [22]
A few fun (and very relevant) stats:
- P&G has paid a dividend for 135 consecutive years and has raised it for 69 consecutive years, cementing its status as a Dividend King. [23]
- For fiscal 2026, management expects to return around $10 billion in dividends and about $5 billion in share repurchases—roughly $15 billion in total cash to shareholders. [24]
That combination of durability and cash yield is why income‑oriented investors—and a lot of analysts—view PG as a core holding in volatile markets, even when the share price looks sleepy. [25]
Innovation: Tide, Pantene and the “Premium Everyday” Strategy
The other half of P&G’s playbook is relentless, sometimes nerdy product innovation.
Recent launches include:
- Tide Original Liquid Detergent: P&G rolled out what it calls the biggest upgrade to Tide’s liquid formula in 20 years in fall 2025, adding roughly 40% more non‑ionic surfactants for better odor and stain removal—without raising the list price. [26]
- Pantene “Abundant & Strong” collection: A new three‑step system (shampoo, conditioner, serum) designed to reduce hair shedding and support scalp health, launching first on Amazon and then at major U.S. retailers. [27]
- Additional brand news in recent weeks includes upgrades in the Aussie curl‑care line, a new Pampers preemie diaper sized for extremely small infants, and a 70‑year anniversary campaign for Cascade dishwashing products. [28]
In Q1 results, that innovation push shows up most clearly in the Beauty and Grooming segments, which grew faster than the company average. Management has explicitly said they are increasing investment in innovation and demand creation even as they cut costs elsewhere. [29]
For investors, this matters because P&G’s ability to raise prices without losing shoppers depends on consumers believing those brands are genuinely better than cheaper alternatives. New formulations and premium line extensions are how you defend that moat.
Legal and Regulatory Watch: Crest on Both Sides of the Courtroom
Not all Crest headlines are created equal.
Kid’s Crest lawsuit moves forward
On November 3, a U.S. federal judge ruled that P&G must face a consumer lawsuit alleging that Kid’s Crest toothpaste packaging misleads parents about how much fluoride‑containing toothpaste is safe for children. [30]
- The plaintiffs argue that showing a full strip of toothpaste with an American Dental Association seal suggests a larger amount is appropriate, despite health authorities advising only a smear for young kids. [31]
- P&G had argued that federal law preempted the claims and that its directions were clear, but the judge allowed state‑law consumer protection claims to proceed.
Financially, this case is unlikely to be material on its own, but it highlights the reputational and regulatory risk that comes with marketing health‑adjacent consumer products.
Crest 3D Whitestrips claims upheld
On a more positive note, an advertising industry body recently found that P&G had provided a reasonable basis for certain stain‑removal claims tied to Crest 3D Whitestrips, following a challenge from a competitor. [32]
Taken together, Crest is both a reminder of P&G’s brand strength and a tiny case study in the kind of scrutiny those brands attract.
What Big Money and Insiders Are Doing
Institutions: mixed flows, but heavy long‑only interest
According to recent filings compiled by MarketBeat and QuiverQuant: [33]
- The New York State Common Retirement Fund increased its PG stake by 0.4% in Q2, to about 2.94 million shares (roughly 0.13% of the company), worth about $468 million, making PG its 21st‑largest holding. [34]
- Across the broader institutional universe, roughly 1,658 investors added shares of PG in their latest quarter while 2,082 reduced positions, including some large trims and some sizable additions by firms like BlackRock and UBS. [35]
So far, that looks like position shuffling in a mega‑cap staple, not an institutional stampede for the exits.
Insiders and Congress: net selling, but not panic
QuiverQuant data suggest that over the past six months: [36]
- P&G insiders executed 25 open‑market trades, all of them sales, with senior executives including the CEO, CFO and several business‑unit heads collectively selling tens of thousands of shares (often as part of pre‑planned programs). [37]
- A MarketBeat tally indicates insiders sold roughly 30,000 shares (~$4.6 million) over the last three months, while still owning about 0.2% of the company. [38]
- Members of the U.S. Congress have traded PG 18 times in six months, with a slight tilt toward purchases. [39]
Insider selling in a mature mega‑cap is common (executives like to diversify and pay for, you know, houses), but the absence of notable insider buying does reinforce the narrative that PG is fairly valued rather than screamingly cheap at current levels.
Analyst Sentiment and the Valuation Debate
There’s a surprisingly lively argument over whether PG is expensive, fairly priced, or outright cheap for a defensive staple.
- One Simply Wall St narrative pegs fair value around $120, implying PG is roughly 24% overvalued at ~$148. [40]
- The same platform’s DCF model, however, suggests fair value closer to $185, implying 20% upside—yes, from the same dataset. [41]
- A recent Seeking Alpha note upgraded PG to “Buy,” arguing that the stock now trades below its historical P/E averages while offering a 2.8% yield above its 5‑ and 10‑year averages, making the sideways share price over the last four years look more like an opportunity than a warning sign. [42]
- Barchart and other analyst roundups show expectations for EPS growth of roughly 2–3% in fiscal 2026, rising to the mid‑single digits beyond that, consistent with the company’s own guidance. [43]
Strip away the spreadsheets and the thesis is pretty simple:
Is a low‑growth, high‑quality, tariff‑buffeted, dividend‑heavy consumer giant worth ~21–22x earnings when bonds yield more than they used to?
If you believe PG can keep nudging prices higher, manage tariff and restructuring costs, and maintain brand dominance, that multiple is tolerable. If you think growth will fade or political risks escalate, it starts to look rich.
Bottom Line: Defensive, Durable… and Under Short‑Term Pressure
As of November 30, 2025, the Procter & Gamble stock story boils down to a few core points:
- Operations: Solid quarter, modest organic growth, and strong cash flow with guidance intact. [44]
- Macro & politics: Tariffs and restructuring are real headwinds, but management has already reduced its tariff cost estimate and is cutting fat elsewhere. [45]
- Geography & portfolio: Exiting Pakistan and low‑margin categories, doubling down on premium beauty, grooming and home‑care brands. [46]
- Income profile: A 2.8–2.9% yield, nearly seven decades of dividend increases, and ~$15 billion in annual cash returns keep PG firmly in dividend‑king territory. [47]
- Sentiment: The share price is lagging, analysts are cautiously bullish, big investors are rotating rather than fleeing, and insiders are mostly selling but not in panic mode. [48]
For investors, PG right now looks less like a rocket ship and more like a sturdy, slightly dented shield: not exciting, but potentially useful if markets get rougher and you like the idea of getting paid every quarter while the macro drama unfolds.
References
1. www.investing.com, 2. www.financecharts.com, 3. stockanalysis.com, 4. www.marketbeat.com, 5. www.quiverquant.com, 6. markets.financialcontent.com, 7. www.pginvestor.com, 8. www.pginvestor.com, 9. www.pginvestor.com, 10. www.pginvestor.com, 11. www.pginvestor.com, 12. www.pginvestor.com, 13. www.scrippsnews.com, 14. www.reuters.com, 15. www.pginvestor.com, 16. www.reuters.com, 17. www.zacks.com, 18. tribune.com.pk, 19. tribune.com.pk, 20. www.reuters.com, 21. www.reuters.com, 22. www.pginvestor.com, 23. www.pginvestor.com, 24. www.pginvestor.com, 25. stockanalysis.com, 26. www.stocktitan.net, 27. www.stocktitan.net, 28. www.stocktitan.net, 29. www.pginvestor.com, 30. www.reuters.com, 31. www.reuters.com, 32. stockanalysis.com, 33. www.marketbeat.com, 34. www.marketbeat.com, 35. www.quiverquant.com, 36. www.quiverquant.com, 37. www.quiverquant.com, 38. www.marketbeat.com, 39. www.quiverquant.com, 40. simplywall.st, 41. simplywall.st, 42. seekingalpha.com, 43. markets.financialcontent.com, 44. www.pginvestor.com, 45. www.scrippsnews.com, 46. tribune.com.pk, 47. www.pginvestor.com, 48. www.marketbeat.com
